Collegium Pharmaceutical, Inc.
COLL · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $924,646 | $1,038,555 | $784,844 | $652,620 |
| - Cash | $70,565 | $238,947 | $173,688 | $186,426 |
| + Debt | $979,911 | $674,283 | $872,787 | $258,750 |
| Enterprise Value | $1,833,992 | $1,473,891 | $1,483,943 | $724,944 |
| Revenue | $631,449 | $566,767 | $463,933 | $276,868 |
| % Growth | 11.4% | 22.2% | 67.6% | – |
| Gross Profit | $377,344 | $326,169 | $209,488 | $150,617 |
| % Margin | 59.8% | 57.5% | 45.2% | 54.4% |
| EBITDA | $341,702 | $308,328 | $173,305 | $86,557 |
| % Margin | 54.1% | 54.4% | 37.4% | 31.3% |
| Net Income | $69,190 | $48,155 | -$25,002 | $71,517 |
| % Margin | 11% | 8.5% | -5.4% | 25.8% |
| EPS Diluted | 1.86 | 1.29 | -0.74 | 1.86 |
| % Growth | 44.2% | 274.3% | -139.8% | – |
| Operating Cash Flow | $204,980 | $274,749 | $124,230 | $103,557 |
| Capital Expenditures | -$1,652 | -$461 | -$1,622 | -$1,944 |
| Free Cash Flow | $203,328 | $274,288 | $122,608 | $101,613 |